111 Capital’s Privia Health PRVA Stock Holding History

111 Capital’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,954	Closed	-$413K	–	645
2025 Q2	$413K	Buy	+17,954	New	+$416K	0.07%	289

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

111 Capital's PRVA Position: Q3 2025 in Review

111 Capital sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 17,954 shares — an estimated $413K sold.

111 Capital first reported a position in PRVA in Q2 2025 and held it in 1 quarter. The position peaked at $413K in Q2 2025. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

111 Capital reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
111 Capital sold 17,954 Privia Health shares in Q3 2025, an estimated $413K.
111 Capital first reported a position in Privia Health in Q2 2025 and held it in 1 quarter.
111 Capital's Privia Health position peaked at $413K in Q2 2025.
259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.